Biosrum Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.20 M
- Revenue Growth 52.51%
- Profit Growth 132.11%
- Ebitda 31.64%
- Net Worth 22.98%
- Total Assets 0.82%
About Biosrum Laboratories
Biosrum Laboratories Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 December 2014 and has a history of Ten years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.20 M.
Surendra Sharma, Sumitra Sharma, and Abinash Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2014PTC274659
-
Company No.
274659
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 2014
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Biosrum Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Sharma
|
Director | 26-Dec-2014 | Current |
|
Sumitra Sharma
|
Director | 26-Dec-2014 | Current |
|
Abinash Sharma
|
Additional Director | 10-Sep-2020 | Current |
Financial Performance of Biosrum Laboratories.
Biosrum Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 52.51% increase. The company also saw a substantial improvement in profitability, with a 132.11% increase in profit. The company's net worth Soared by an impressive increase of 22.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biosrum Laboratories?
In 2021, Biosrum Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Unicrowd Secure India Nidhi LimitedSurendra Sharma, Sumitra Sharma and 1 more are mutual person
-
Iwell Retails India Private Limited
Abinash Sharma is a mutual person
Charges (Loans)
₹2.20 M
₹0
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2016 | United Bank Of India | ₹2.20 M | Open |
How Many Employees Work at Biosrum Laboratories?
Unlock and access historical data on people associated with Biosrum Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biosrum Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosrum Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
